Maggie Yuen

Track

Insider profile

Currently holds a position at Penumbra, Inc.

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -16% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer Penumbra, Inc. Dec. 2, 2019 -
Maggie Yuen's trades of AtriCure Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US AtriCure Inc (ATRC)
Transaction date
Sale
Price
383.41
Quantity 52,966 -32.8%
Value US$3,688,306
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
58.17
Quantity 48,842
Value US$339,332
Transaction date
Planned sale
Price
243.24
Quantity 83,151 -43.8%
Value US$2,639,207
Transaction date
Proposed sale
Price
342.30
Quantity 2,432
Value US$832,474
US AtriCure Inc (ATRC)
Transaction date
Sale
Price
35.72
Quantity 3,000 -20.9%
Value US$107,160
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
35.72
Quantity 3,000
Value US$107,158
Transaction date
Planned sale
Price
250.00
Quantity 2,000 -13.4%
Value US$500,000
Transaction date
Proposed sale
Price
250.00
Quantity 2,000
Value US$500,000
Transaction date
Planned sale
Price
299.01
Quantity 2,000 -12.5%
Value US$598,020
Transaction date
Proposed sale
Price
299.01
Quantity 2,000
Value US$598,020
Transaction date
Planned sale
Price
288.74
Quantity 360 -2.3%
Value US$103,946
Transaction date
Planned sale
Price
286.43
Quantity 500 -3.1%
Value US$143,215
Transaction date
Planned sale
Price
285.70
Quantity 590 -3.5%
Value US$168,563
Transaction date
Planned sale
Price
284.86
Quantity 300 -1.8%
Value US$85,458
Transaction date
Planned sale
Price
283.25
Quantity 250 -1.4%
Value US$70,812
Transaction date
Proposed sale
Price
286.00
Quantity 2,000
Value US$571,995
US AtriCure Inc (ATRC)
Transaction date
Sale
Price
24.07
Quantity 3,500 -28.1%
Value US$84,245
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
24.07
Quantity 3,500
Value US$84,245
US AtriCure Inc (ATRC)
Transaction date
Sale
Price
47.04
Quantity 4,313 -47.9%
Value US$202,884
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
47.04
Quantity 4,313
Value US$202,874
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-07 2026-08-05
US AtriCure Inc (ATRC)
S Sale
52,966 -32.8%
383.41
US$3,688,306 		52,966 -32.8% 383.41 US$3,688,306
2026-08-05 2026-08-05
US AtriCure Inc (ATRC)
PrS Proposed sale
48,842
58.17
US$339,332 		48,842 58.17 US$339,332
2026-03-04 2026-03-02
PlS Planned sale
83,151 -43.8%
243.24
US$2,639,207 		83,151 -43.8% 243.24 US$2,639,207
2026-03-02 2026-03-02
PrS Proposed sale
2,432
342.30
US$832,474 		2,432 342.30 US$832,474
2025-11-25 2025-11-21
US AtriCure Inc (ATRC)
S Sale
3,000 -20.9%
35.72
US$107,160 		3,000 -20.9% 35.72 US$107,160
2025-11-21 2025-11-21
US AtriCure Inc (ATRC)
PrS Proposed sale
3,000
35.72
US$107,158 		3,000 35.72 US$107,158
2025-08-15 2025-08-13
PlS Planned sale
2,000 -13.4%
250.00
US$500,000 		2,000 -13.4% 250.00 US$500,000
2025-08-13 2025-08-13
PrS Proposed sale
2,000
250.00
US$500,000 		2,000 250.00 US$500,000
2025-05-06 2025-05-02
PlS Planned sale
2,000 -12.5%
299.01
US$598,020 		2,000 -12.5% 299.01 US$598,020
2025-05-02 2025-05-02
PrS Proposed sale
2,000
299.01
US$598,020 		2,000 299.01 US$598,020
2025-03-05 2025-03-03
PlS Planned sale
360 -2.3%
288.74
US$103,946 		360 -2.3% 288.74 US$103,946
2025-03-05 2025-03-03
PlS Planned sale
500 -3.1%
286.43
US$143,215 		500 -3.1% 286.43 US$143,215
2025-03-05 2025-03-03
PlS Planned sale
590 -3.5%
285.70
US$168,563 		590 -3.5% 285.70 US$168,563
2025-03-05 2025-03-03
PlS Planned sale
300 -1.8%
284.86
US$85,458 		300 -1.8% 284.86 US$85,458
2025-03-05 2025-03-03
PlS Planned sale
250 -1.4%
283.25
US$70,812 		250 -1.4% 283.25 US$70,812
2025-03-03 2025-03-03
PrS Proposed sale
2,000
286.00
US$571,995 		2,000 286.00 US$571,995
2024-08-19 2024-08-15
US AtriCure Inc (ATRC)
S Sale
3,500 -28.1%
24.07
US$84,245 		3,500 -28.1% 24.07 US$84,245
2024-08-15 2024-08-15
US AtriCure Inc (ATRC)
PrS Proposed sale
3,500
24.07
US$84,245 		3,500 24.07 US$84,245
2023-05-30 2023-05-26
US AtriCure Inc (ATRC)
S Sale
4,313 -47.9%
47.04
US$202,884 		4,313 -47.9% 47.04 US$202,884
2023-05-26 2023-05-26
US AtriCure Inc (ATRC)
PrS Proposed sale
4,313
47.04
US$202,874 		4,313 47.04 US$202,874